Clinical trial
Nicotine Patch Bioequivalence Study
NCT01658202 is registered in ClinicalTrials.gov with Pierre Fabre Medicament as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nicotine Patch Bioequivalence Study
- Lead sponsor
- Pierre Fabre Medicament
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- September 30, 2012
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy smokers